INTERNATIONAL PATENT: MEMORIAL SLOAN-KETTERING CANCER CENTER, MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES, SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH FILES APPLICATION FOR "COMBINATION THERAPY WITH CYTOKINE INDUCED MEMORY- LIKE NATURAL KILLER (CIMN) CELLS AND PD-L1 INHIBITORS TO TREAT RELAPSED OR REFRACTORY ACUTE MYELOGENOUS LEUKEMIA"

GENEVA, April 30 -- MEMORIAL SLOAN-KETTERING CANCER CENTER (1275 York AvenueNew York, New York 10065), MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (1275 York AvenueNew York, New York 10065), SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (1275 York AvenueNew York, New York 10065) filed a patent application (PCT/US2024/051589) for "COMBINATION THERAPY WITH CYTOKINE INDUCED MEMORY- LIKE NATURAL KILLER (CIMN) CELLS AND PD-L1 INHIBITORS TO TREAT RELAPSED OR REFRACTORY ACUTE MYELOGENOUS LEUKEMIA" on Oct 16, 2024. With publication no. WO/2025/085525, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is ma...